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http://dxObjective: Vascular endostaplers are bulky and can be dangerous when dividing small pulmonary arterial (PA)
branch vessels during video-assisted thoracoscopic lobectomy. We aimed to evaluate and compare the
immediate efficacy of modern energy sealing devices in an ex vivo PA sealing model.
Methods: Patients undergoing anatomical lung resection or lung transplantation were recruited for a prospective
cohort pilot study. Four devices were evaluated: Harmonic Ace (Ethicon, Cincinnati, Ohio), Thunderbeat
(Olympus, Tokyo, Japan), LigaSure (Covidien, Boulder, Colo), and Enseal (Ethicon; Cincinnati, Ohio). After
anatomical lung resection, the PA branches were dissected in vitro. Sealing was then performed with 1 of the
sealing devices, the vessel was slowly pressurized, and the bursting pressure was recorded.
Results: Forty-ninePAbrancheswere sealed in14patients.ThemeanPAbranchdiameterwas7.4mm(1.8-14.5mm).
Ten patients had normal PA pressure and 3 had PA hypertension. The mean bursting pressure in each was as follows:
HarmonicAce group, 415.5mmHg (137.1-1388.4mmHg), Thunderbeat group, 875mmHg (237.1-2871.3mmHg);
LigaSure group, 214.7 mm Hg (0-579.6 mm Hg); Enseal group, 133.7 mm Hg (0-315.38 mm Hg). There were
2 complete sealing failures: LigaSure (diameter 6.78 mm) and Enseal (diameter 8.3 mm).
Conclusions: In this pilot study to examine energy sealing of PA branches in a simulated ex vivomodel, vascular
sealing using energy was effective and was able to sustain high intraluminal bursting pressures. Further research
is needed to determine the in vivo and long-term safety of PA branch energy sealing. (J Thorac Cardiovasc Surg
2014;148:3219-23)Video-assisted thoracic surgery (VATS) lobectomy is
currently the preferred treatment modality for stage I
non–small cell lung cancer in many centers. Although it
is a safe and effective technique in experienced hands,
only a minority of anatomical pulmonary resections are
currently being performed by VATS. In an analysis using
the Nationwide Inpatient Sample database in the United
States, only 15% of anatomical lung resections were
performed by VATS.1
Although effective and safe in experienced hands, VATS
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Scomplications can be catastrophic at times. Complications
include pulmonary vascular injuries (pulmonary artery
[PA], pulmonary vein) necessitating urgent conversion to
open thoracotomy and even death.2 Published conversion
rates range from 2% to 20%.3-6 The technical difficulty
and danger of VATS lobectomy are primarily related to
PA branch dissection and manipulation and this is the
main issue for many thoracic surgeons regarding the
adoption of VATS lobectomy as the primary treatment
modality for stage I lung cancer.
Vascular ligation and sealing using energy devices may
allow the surgeon to safely seal PA branches with minimal
dissection, manipulation, and possibly lower vascular injury
rates. Energy sealing might be superior to stapling devices
because it eliminates the need for excessive tissue
dissection around the pulmonary vessels, which in turn
may decrease the incidence of vascular injuries during
VATS lobectomy.
The primary objective of the current study was to
evaluate and compare the immediate efficacy of modern
energy sealing devices in PA branch sealing and division
using an ex vivo PA sealing model.
MATERIALS AND METHODS
The study consists of a prospective, preclinical, feasibility pilot study
(ClinicalTrials.gov Identifier: NCT01871597) to evaluate modern energy
sealing devices for sealing PA branches of various sizes.
Patients with nonhilar tumors undergoing anatomical pulmonary lung
resection either by VATS or thoracotomy were enrolled prospectively.diovascular Surgery c Volume 148, Number 6 3219
Abbreviations and Acronyms
EN ¼ Enseal (Ethicon, Cincinnati, Ohio)
HA ¼ Harmonic Ace (Ethicon, Cincinnati, Ohio)
LS ¼ LigaSure (Covidien, Boulder, Colo)
PA ¼ pulmonary artery
TB ¼ Thunderbeat (Olympus, Tokyo)
VATS ¼ video-assisted thoracic surgery




SThe study also included explanted lungs from lung transplant recipients.
Patients with hilar lung tumors with proximity to major PAs, which may
have affected the integrity of the pathologic vascular margin, were
excluded.
The study was approved by the institutional review board at the Centre
de Recherche, Centre Hospitalier de l’Universite de Montreal, Montreal,
Quebec, Canada.
Eligible patients included (1) patients with nonhilar tumors undergoing
anatomical pulmonary lung resection by either VATS or open thoracotomy,
(2) patients undergoing lung explant before lung transplantation, and (3)
patients undergoing multiple visceral organ retrieval in which the lungs
were not suitable for transplant. All patients were prospectively enrolled
and gave consent before pulmonary explantation. Exclusion criteria
included inability to consent (patient or family member in case of recipient
organ), patient less than 18 years old, and patients with hilar tumors in
proximity to major PAs that might affect the integrity of the pathologic
vascular margin.
Intraoperative techniques did not differ from standard resection
techniques and blood vessel ligation was performed according to standard
operative procedures using either endostaplers or direct ligation of the
pulmonary vessels.
After resection and removal of the resected specimen, the specimen was
examined ex vivo, in a nonsterile field in the operative room. The lobar PA
and its main segmental branches were sharply dissected. Cannulation of a
major segmental PA branch was performed using a pressurization and
monitoring device specifically designed for this study (Figure 1). The
cannula was secured with a 2-0 silk suture.
The equipment for vascular pressurization and pressure monitoring/
recording was designed, developed and tested specifically for this project.
A prototype vascular pressurization device with real-time, ultraprecision, in-
tralumenal vascular pressuremonitoring (up to 10 recordings per second) and
software was developed by our research team in conjunction with Neptronic
(Saint Laurent, Quebec, Canada). This device allows for controlled vascular
pressurization with precise monitoring of pressure inflection and burst pres-
sures. All pressure measurements were recorded and the time from initial
vascular pressurization to PA bursting pressure was presented graphically.
All distal segmental branches of the PA were ligated to maintain the
pressure throughout the catheterized segmental branch. An initial pressure
of 25 mm Hg was obtained by inflating the PA vessel with normal saline.
The lobar PA and the main segmental branch diameters were measured us-
ing a digital caliper (Mastercraft Digital Caliper #58-6800-4; Canadian
Tire, Toronto, Ontario, Canada) from vascular adventitia to adventitia.
The lobar PA and the main segmental arteries were sealed using 1 of the
following devices: Harmonic Ace (HA) (Ethicon, Cincinnati, Ohio),
Thunderbeat (TB) (Olympus, Tokyo, Japan), LigaSure (LS) (Covidien,
Boulder, Colo), and Enseal (EN) (Ethicon, Cincinnati, Ohio). The sealing
was performed with an intravascular pressure of 25 mm Hg in order to
simulate normal human PA pressures. A new vascular sealing device was
used for each patient. Each specimen’s PA branches were sealed with the
same device.
After division of the PA, normal saline solution was injected through the
controlled pressure syringe pump in order to achieve an intralumenal
vascular pressure until the bursting pressure was reached. Intraluminal3220 The Journal of Thoracic and Cardiovascular Surpressure was recorded every 0.125 seconds. This permitted the exact
recording of all pressure changes and ascertainment of the precise bursting
pressure, which was manifested by a sudden drop in intraluminal pressure
despite maintained saline inflation.
The preoperative PA pressurewas ascertained by reviewing the echocar-
diography results performed during the preceding year. Asymptomatic
patients and patients without underlying pulmonary conditions that might
predispose to pulmonary hypertension were considered to have a normal
PA pressure in the absence of a formal echocardiogram.
Analysis consisted of between-group comparisons of the efficacies and
bursting pressure of each sealing method studied. The primary outcome for
analysis was the gross intergroup comparisons of mean PA burst pressures.
Statistical testing comparing between-group differences was not performed
because of the small sample size and heterogeneity between groups in this
preliminary pilot study.RESULTS
Energy sealing of PA branches was performed on 14
anatomical lung resections in 14 patients; 7 women and 7
men, aged from 27 to 79 years (mean, 60 years). Eleven
patients were operated on for lung cancer and 3 specimens
were explanted recipient lungs from transplant recipients
(2 with idiopathic pulmonary fibrosis, 1 with cystic
fibrosis). No patient had systemic vascular disease. Five
patients had systemic hypertension. Five patients had
diabetes. Four patients had varying degrees of renal disease.
Eleven patients had normal PA pressures. One patient had
severe pulmonary hypertension with a mean PA pressure of
52 mm Hg. Two patients had mild to moderate pulmonary
hypertension (mean, 46 mm Hg and 37 mm Hg).
In the patients undergoing lobectomy, there were 3 right
upper lobes, 4 right lower lobes, and 4 left upper lobes. The
mean number of energy-sealed arteries in lobectomy cases
was 1.55 (range, 1-3). In cases of recipient lungs from lung
transplantation, the PAs of both lungs were dissected and
energy sealing was performed. The mean number of
energy-sealed arteries in lung transplant recipient lungs
was 10.67 (range, 4-17).
Energy sealing was performed in 49 lobar and segmental
PA branches. The diameter of sealed arteries ranged from
1.81 mm to 14.52 mm (mean, 7.47 mm; standard deviation
[SD], 2.71 mm) (Figure 2).
HAwas used in 5 patients and a total of 15 arteries were
sealed. Two patients had documented pulmonary hyperten-
sion in this group (mean PA pressures, 52 mm Hg and 37
mm Hg). PA branch diameter ranged from 3.55 mm to
12.71 mm (mean, 6.56 mm). Bursting pressure in PA
branches ranged from 137.1 mm Hg to 1388.4 mm Hg
(mean, 415.5 mm Hg; SD, 361.18). There were no sealing
failures in any PA branch sealed with the HA.
LS was used in 4 patients and a total of 12 arteries were
sealed. All patients in the LS group had normal PA
pressures. PA branches ranged from 1.81 mm to
14.52 mm (mean, 7.44 mm). There was 1 complete sealing
failure in 1 patient manifested by leakage of saline
immediately after sealing and the inability of the vessel togery c December 2014
TABLE 1. Energy devices used in the study





Harmonic Scalpel (Ethicon, Cincinnati, Ohio) Harmonic Ace 36 cm, 5 mm Ultrasound adaptive tissue technology 0-3
LigaSure (Covidien, Boulder, Colo) Dolphin Tip 37 cm, 5 mm Advanced bipolar 4.4
Enseal (Ethicon, Cincinnati, Ohio) Enseal Trio 35 cm, 5 mm Advanced bipolar 1.1
Thunderbeat (Olympus, Tokyo, Japan) TB-0545FC, Front Grip 45 cm, 5 mm Ultrasonic and advanced bipolar Unknown
Liberman et al Evolving Technology/Basic Sciencehold pressurized saline (diameter, 6.78mm). Another vessel
had a bursting pressure of 60 mm Hg (diameter, 7.47 mm).
Bursting pressures ranged from 0 mm Hg to 579.6 mm Hg
(mean, 214.74 mm Hg; SD, 170.21 mm Hg). In the LS
group, smaller PA branches tended to have higher bursting
pressures than larger ones.
TB was used in 3 patients and a total of 13 arteries
were sealed. One patient in this group had pulmonary
hypertension (mean PA pressure, 46 mm Hg). PA branch
diameters in this group ranged from 4.46 mm to
10.15 mm (mean, 8.01 mm). There were no sealing failures
in any PA branch sealed with the TB. Bursting pressures
ranged from 237.08 mm Hg to 2871.31 mm Hg (mean,
847.96 mm Hg; SD, 682.52 mm Hg).
EN was used in 3 patients and a total of 9 arteries
were sealed. All patients had normal PA pressures
preoperatively. PA branch diameters ranged from
4.98 mm to 12.89 mm (mean, 8.25 mm). There was 1 com-
plete failure in PA sealing using EN (diameter, 8.31 mm).
Three PA branches had bursting pressure less than
100 mm Hg (53.13 mm Hg, 63.65 mm Hg, and
74.67 mm Hg). Bursting pressures in the EN group ranged
from 0 to 315.38 mm Hg (mean, 133.67 mm Hg; SD,
105.89 mm Hg).
DISCUSSION
PA ligation and sealing is a critical step in anatomical
lung resection. During VATS lobectomy, PA sealing is typi-
cally performed using endostaplers or clips.7,8 Endostaplers
are effective for ligating pulmonary vessels with burst
pressures in porcine PAs reaching up to 297 mm Hg.9
However, endostaplers are bulky, rigid, and have a largeFIGURE 1. Dissected and ligated segmental and subsegmental pulmonary ar
cannulation of 1 arterial branch (A). Pulmonary artery after LigaSure sealing (
The Journal of Thoracic and Carfootprint making application and stapling of pulmonary
vessels awkward, difficult, and sometimes dangerous.
Intraoperative surgical complications occurring during
VATS lobectomy can be sometimes be catastrophic.
Complications include pulmonary vascular injuries (PA,
pulmonary vein) necessitating urgent conversion to open
thoracotomy and even death.2 Published conversion rates
range from 2% to 20%.3-6 In a Canadian study published
in 2011 on the causes of VATS conversion to thoracotomy
for 237 procedures, the conversion rate from VATS to
open thoracotomy was 13.5%.2 PA injury alone constituted
37.5% of all conversions. Flores and colleagues10
demonstrated catastrophic complications in 13 cases in
their series of 633 cases. Five patients had PA injury or
transection. Proper dissection of all tissue around PA
branches is sometime difficult, especially in the presence
of adhesions or large, calcified, lymph nodes and may
increase the risk of vascular injury.
Although it is a safe and effective technique in
experienced hands, only a minority of anatomical
pulmonary resections are currently being performed by
VATS. In an analysis using the Nationwide Inpatient
Sample database in the United States, only 15% of
anatomical lung resections were performed by VATS.1
However, according to the procedures recorded in the
Society of Thoracic Surgeons database (voluntary contribu-
tion), the number of VATS anatomical lung resections
performed in North America is increasing (8% in 2003 vs
44.7% in 2010).11 In Europe, less than 10% of all major
anatomical lung resections are performed by VATS.10
The technical difficulty and danger of VATS lobectomy is
in part related to PA branch manipulation, dissection,tery branches. Pressurization and pressure recording is achieved through
B).





FIGURE 2. Average bursting pressures of energy sealing devices. HA,
Harmonic Ace; LS, LigaSure; TB, Thunderbeat.




Sstapling, and division. PAmanipulation is the main issue for
many thoracic surgeons regarding the adoption of VATS
lobectomy. An effective and safe way to decrease the
manipulation and wide dissection required on the PA
branches is required to make these procedures a little safer
and therefore more prevalent.
Others have evaluated energy sealing of PA vessels.
Albanese and colleagues12 performed pediatric VATS
lobectomy using LS. They reported 14 VATS lobectomies
in children aged 3 to 15 months. LS was used to transect
the main pulmonary vessels and complete the fissure if
needed. There were no intraoperative or postoperative
complications.12 Another series of 6 energy VATS
lobectomies in children (10 months old) was published
in 2006. LS was used to seal the pulmonary lobar
vessels. There were no intraoperative complications. Two
patients had postoperative hemothorax, which resolved
spontaneously.13
Energy devices have been evaluated and used in the
abdomen to seal systemic vessels and have been proved to
be effective.14,15 Although thermal spread is always a
concern in energy sealing, modern energy sealing
devices produce much less lateral thermal spread than
conventional bipolar devices (Table 1).16-21
The ability of the sealed arteries to resist intraluminal
pressure is the most important factor determining the safety
of energy sealing. Santini and colleagues22 decided that a
bursting pressure of sealed PA branches greater than 150
mm Hg is acceptable and safe. Although this value was
used in subsequent studies,23 this critical bursting pressure
has not been validated. We have observed that patients
with higher PA pressures had higher PA burst pressures after
vascular energy sealing. This is likely a result of the
increased thickness of the elastic fiber layer in the arterial
wall caused by long-standing increased intraluminal
pressures.
Most of the patients enrolled in the current study had
normal PAs. Patients with higher PA pressure were not
excluded. If patients with abnormal PAs are excluded, the3222 The Journal of Thoracic and Cardiovascular Suraverage burst pressure was lower in all groups
(HA, 326.08 mm Hg; LS, 214.74 mm Hg; EN, 83.31 mm
Hg; and TB, 573.55 mm Hg). PA hypertension seems to
be a protective factor in PA vascular sealing. However,
even normal pulmonary vessels sealed with acceptably
high burst pressures.
There was a significant difference in efficacy and burst
pressures based on the energy platform used. Devices using
ultrasound-sealing technology (HA) seemed superior to
advanced bipolar technology (LS and EN) in sealing PAs.
Moreover, 2 complete sealing failures were observed in
the LS and EN groups. Combining the 2 technologies
(TB) resulted in increased mean bursting pressures.
Tanaka and colleagues24 used the HA scalpel to seal 43
PAs and 13 pulmonary veins in an animal model. The
bursting pressure of the arteries sealed was more than 100
mm Hg in all arteries except 1. Tsunezuka and colleagues25
evaluated the bursting pressure of PAs sealed with the LS
device in a human model during VATS lung resections.
LS was used to seal segmental and subsegmental PAs less
than 5 mm in diameter. High bursting pressures were
observed. There were higher bursting pressures in PAs
smaller than 5 mm compared with PAs larger than 5 mm.
Lesser and colleagues26 compared bursting pressures in
PAs sealed with LS with suture-ligated arteries. The mean
bursting pressure in small PAs (3-5 mm) was 315 mm Hg
and 156 mm Hg in larger PAs (6-8 mm). To date, there
have been no studies evaluating the use of EN and TB in
PA sealing.
The results of the present study were similar to others
except for the PA branches sealed with the HA. Larger
PAs sealed with HA burst at higher bursting pressures.
Tanaka and colleagues18 observed that histologic
examination of the PAs sealed with HA in a swine model
showed degeneration of the collagen and elastic fibers and
tight sealing at the resected stump of the PA. Lesser and
colleagues26 observed that histologic examination of the
PAs sealed with LS revealed only adventitial fusion with
retraction and invagination of the intima and media layers
without fusion. This histologic difference in the mechanism
of PA sealing may explain the lower bursting pressures with
larger arteries sealed by either ultrasound or advanced
bipolar technology.
Limitations
The present study is a preclinical study providing pilot
data using 4 commonly used advanced energy sealing
devices. The sample size is small (14 patients and 49
PAs). Larger samples with different PA pressures and vessel
sizes will be needed to confirm the pilot data gained from
this study. Histologic examinations will be needed in future
studies to compare and evaluate the different sealing
mechanisms of the advanced energy sealing devices. Saline
was used instead of blood to pressurize the vessels in thisgery c December 2014
Liberman et al Evolving Technology/Basic Sciencestudy. During vascular sealing, when the vessel is sealed, it
is completely occluded with pressure from the jaws of the
device and therefore there is no blood within the lumen.
Using blood in the pressurization system would have
required drawing blood from the patient, which would
have caused undue risk to the participants, and therefore
saline was used instead.CONCLUSIONS
In this pilot study evaluating 4 commercially available
energy devices, energy sealing of PA branches was effective
and shown to sustain high intraluminal bursting pressures in
a simulated ex vivo environment. In this pilot study with a
small number of patients, ultrasound technology seemed
to be superior to advanced bipolar technology, but for that
conclusion to be verified, a larger group of patients must
be evaluated. Further research is needed to determine the
long-term safety of PA energy sealing in an in vivo
environment.
Vascular pressurization and measurement devices were
designed and produced specifically for this study by Neptronic,
Saint Laurent, Quebec, Canada.References
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